---
tags:
  - hypertension
---

# First-line therapies

- AHA/ACC 2017: [[Thiazides|thiazide diuretics]], [[Calcium Channel Blockers (CCBs)|CCBs]], and [[Renin-angiotensin-aldosterone system inhibitors (RAASi)|ACE/ARBs]] (IA recommendation)
	- Recommend dual therapy with fixed-dose combo if Stage 2 HTN (i.e., SBP ≥ 140 *or* DBP ≥ 90) and an average BP > 20/10 mmHg above BP target (IA)
- ESC/ESH 2018
	- ![[Anti-Hypertensive Medications-20241220142119966.webp]]